Document is current
Any future updates will be listed below
-
Authors
Frei, Ana Leni
Khan, Amjad
Oberson, Raphaël
Reinhard, Stefan
Banz, Yara
Meeuwsen, Frédérique
Janowczyk, Andrew
Grobholz, Rainer
Dawson, Heather E.
Lugli, Alessandro
Ilié, Marius
van der Laak, Jeroen
Zlobec, Inti https://orcid.org/0000-0001-6741-3000
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
University of Bern
- License Information
-
More Information
Article History
Received: 30 April 2025
Revised: 12 June 2025
Accepted: 19 June 2025
First Online: 4 July 2025
Declarations
:
: All image crop and participant scores were collected anonymously. Under Swiss law, this study does not require a particular ethics approval.
: Jeroen van der Laak was a member of the advisory boards of Philips, the Netherlands, and ContextVision, Sweden, and received research funding from Philips, the Netherlands; ContextVision, Sweden; and Sectra, Sweden, in the last 5 years. He is chief scientific officer (CSO) and shareholder of Aiosyn BV, the Netherlands. Inti Zlobec is on the scientific advisory board of Aiforia, Finland. Andrew provides consulting for Merck and Roche, the latter of which he also has a sponsored research agreement.
